Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

J.P. Morgan Remains a Hold on Centene (CNC)

Tipranks - Tipranks - Fri Mar 27, 7:44AM CDT

In a report released yesterday, John Stansel from J.P. Morgan maintained a Hold rating on Centene, with a price target of $41.00. The company’s shares closed yesterday at $32.73.

Claim 30% Off TipRanks Premium

Stansel covers the Healthcare sector, focusing on stocks such as Centene, Molina Healthcare, and Henry Schein. According to TipRanks, Stansel has an average return of -7.6% and a 38.46% success rate on recommended stocks.

In addition to J.P. Morgan, Centene also received a Hold from TipRanks – Google’s Google Medical – Healthcare Plans in a report issued yesterday. However, on March 13, Goldman Sachs assigned a Sell rating to Centene (NYSE: CNC).

See today’s best-performing stocks on TipRanks >>

Based on Centene’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $49.73 billion and a GAAP net loss of $1.1 billion. In comparison, last year the company earned a revenue of $40.81 billion and had a net profit of $283 million

Read More on CNC:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).